abstract |
An isolated or recombinant anti-EGFL6 monoclonal antibody is provided. In some cases, the antibodies of the embodiments can be used for detection, diagnosis and / or therapeutic treatment of human diseases, such as cancer. [Selected figure] Figure 1 |